Wentzville, MO, United States of America

Joseph Walter Strohbach

This inventor holds 39 USPTO granted patents and 9 published patent applications, plus 8 CIPO patents and 11 EPO patents, primarily in Antiviral Compounds. Top assignees: Pfizer Corporation, Pharmacia & Upjohn Company, Cystic Fibrosis Foundation. Active years: 1997-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Walter Strohbach. Retrieved from https://idiyas.com/inventor/joseph-walter-strohbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 39 (Patent Applications = 9)

% Patents Active = 82.1

CIPO Patents = 8 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 17)

Average Co-Inventor Count = 8.3

ph-index = 10

Forward Citations = 296(Granted Patents)

Location History:

Mendon, MI (US) (1997 - 2004)
Wentzville, MO (US) (2015 - 2023)

Company Filing History:

Pharmacia & Upjohn Company

patents

4 out of 4

Cystic Fibrosis Foundation

patents

4. 3 out of 5

Cystic Fibrosis Foundation Therapeutics, Inc.

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

CFTR Potentiators

PDE4 Inhibitors

Bicyclic Compounds

Pyrrolopyrimidines

Benzimidazole Derivatives

Antiviral Agents

Heterocycle Carboxamides

Quinolinecarboxamides

Pyrazolopyridines

Vanin-1 Inhibitors

Bicyclic Heteroaryl Derivatives

Retroviral Infections

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760019 - SIK inhibitors (2026-10-13),

2. 12612409 - Pyrrolopyrimidines as CFTR potentiators (2026-04-28),

3. 12202836 - Bicyclic-fused heteroaryl or aryl compounds (2025-01-21),

4. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),

5. 11661419 - Benzimidazole derivative compounds and uses thereof (2023-05-30),

6. 11559538 - Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors (2023-01-24),

7. 10946031 - PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol (2021-03-16),

8. 10906888 - Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme (2021-02-02),

9. 10793579 - Bicyclic-fused heteroaryl or aryl compounds (2020-10-06),

10. 10766904 - Bicyclic heteroaryl derivatives as CFTR potentiators (2020-09-08),

11. 10494374 - Pyrrolopyrimidines as CFTR potentiators (2019-12-03),

12. 10377762 - Bicyclic heteroaryl derivatives as CFTR potentiators (2019-08-13),

13. 10329302 - Bicyclic-fused heteroaryl or aryl compounds (2019-06-25),

14. 10316018 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (2019-06-11),

15. 10301315 - Pyrrolopyrimidines as CFTR potentiators (2019-05-28),

Title: The Innovative Journey of Joseph Walter Strohbach

Introduction: Joseph Walter Strohbach, a visionary inventor hailing from Wentzville, MO (US), has made significant contributions to the world of innovations with his creative mind and dedication to progress.

Latest Patents: Joseph Walter Strohbach holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to existing problems. His recent patents include advancements in sustainable energy technologies and cutting-edge medical devices.

Career Highlights: Throughout his illustrious career, Joseph Walter Strohbach has been at the forefront of groundbreaking inventions that have revolutionized industries. His commitment to pushing the boundaries of what is possible has led to numerous successful ventures and accolades.

Collaborations: Joseph Walter Strohbach has collaborated with leading experts in the field, including renowned researchers, engineers, and scientists. These collaborations have not only enriched his own work but have also paved the way for interdisciplinary innovations that have the potential to change the world.

Conclusion: In conclusion, Joseph Walter Strohbach's passion for innovation, coupled with his relentless drive to make a difference, has established him as a prominent figure in the world of inventors. His remarkable journey continues to inspire future generations to think outside the box and pursue their inventive dreams.

Profile summary based on public USPTO records.